January 4, 2018 / 3:38 PM / 6 months ago

BRIEF-DTRA Awards VenatoRx Up To $16 Mln To Develop Antibiotic For Biodefense Purposes

Jan 4 (Reuters) - Venatorx Pharmaceuticals:

* DEFENSE THREAT REDUCTION AGENCY AWARDED CO UP TO $16 MILLION TO DEVELOP ANTIBIOTIC FOR BIODEFENSE APPLICATIONS Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below